This page has been archived on the Web
Information identified as archived is provided for reference, research or recordkeeping purposes. It is not subject to the Government of Canada Web Standards and has not been altered or updated since it was archived. Please contact us to request a format other than those available.
Cloxacillin Sodium 1000 mg for injection (2017-01-27)
- Starting date:
- January 27, 2017
- Posting date:
- February 3, 2017
- Type of communication:
- Drug Recall
- Subcategory:
- Drugs
- Hazard classification:
- Type III
- Source of recall:
- Health Canada
- Issue:
- Product Safety
- Audience:
- General Public, Healthcare Professionals, Hospitals
- Identification number:
- RA-62162
Reason
Out of trend result for potency during stability testing.
Depth of distribution
Wholesaler, retailer, hospitals, pharmacies; Alberta, British Columbia, Manitoba, New Brunswick, Newfoundland, Nova Scotia, Ontario, Quebec, Saskatchewan
Affected products
Cloxacillin Sodium 1000 mg for injection
DIN, NPN, DIN-HIM
DIN 01975447
Dosage form
Powder for solution
Strength
Cloxacillin Sodium 1000 mg
Lot or serial number
GB7464
Companies
- Recalling Firm
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA
- Marketing Authorization Holder
-
Teva Canada Limited
30 Novopharm Court
Toronto
M1B 2K9
Ontario
CANADA